NCT02850536View on ClinicalTrials.gov

CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

September 17, 2021

Conditions
Liver Metastases
Interventions
BIOLOGICAL

anti-CEA CAR-T cells

Gene modified patient T cells

Trial Locations (2)

80045

University of Colorado Hospital, Aurora

02908

Roger Williams Medical Center, Providence

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

collaborator

Sorrento Therapeutics, Inc.

INDUSTRY

lead

Roger Williams Medical Center

OTHER

NCT02850536 - CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer | Biotech Hunter | Biotech Hunter